Leadhexa Biotechnologies Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Leadhexa Biotechnologies General Information
Description
Developer of molecular technology designed to discovered enzyme Manganese Superoxide Dismutase. The company's technology demonstrated efficacy in numerous preclinical models including actinic keratosis, radiation protection, protection of kidney damage due to cyclosporine, liver cirrhosis and liver ischemia-reperfusion injury, enabling doctors to remove supra-stoichiometric amounts of reactive oxygen species to enter in the Mitochondria and cells.
Contact Information
Website
www.leadhexa.comCorporate Office
- 953 Indiana Street
- San Francisco, CA
- United States
Corporate Office
- 953 Indiana Street
- San Francisco, CA
- United States
Leadhexa Biotechnologies Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 01-Jan-2015 | Completed | Out of Business | |||
2. Accelerator/Incubator | Completed | Startup | ||||
1. Accelerator/Incubator | Completed | Startup |
Leadhexa Biotechnologies FAQs
-
When was Leadhexa Biotechnologies founded?
Leadhexa Biotechnologies was founded in 2014.
-
Where is Leadhexa Biotechnologies headquartered?
Leadhexa Biotechnologies is headquartered in San Francisco, CA.
-
What industry is Leadhexa Biotechnologies in?
Leadhexa Biotechnologies’s primary industry is Biotechnology.
-
Is Leadhexa Biotechnologies a private or public company?
Leadhexa Biotechnologies is a Private company.
-
What is Leadhexa Biotechnologies’s current revenue?
The current revenue for Leadhexa Biotechnologies is
.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »